Trending...
- Massachusetts: Governor Maura Healey Lifts States of Emergency
- Boston: Mayor Wu Announces New Roxbury Neighborhood Liaison, Asha Janay
- Boston: Councilor Sharon Durkan Delivers Her Maiden Speech
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that management will present at the Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023, at 2:40 p.m. PT (5:40 p.m. ET).
A live webcast of the presentation will be available on the Investor Relations page of Karuna's website at investors.karunatx.com. A replay of the webcast will also be archived for up to 30 days on Karuna's website following the completion of the event.
More on Boston Chron
About Karuna
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples' lives. For more information, please visit www.karunatx.com.
Contacts
Investors:
Alexis Smith
+1 (518) 338-8990
asmith@karunatx.com
Media:
Bob Josefsberg
+1 (646) 734-3584
bjosefsberg@karunatx.com
A live webcast of the presentation will be available on the Investor Relations page of Karuna's website at investors.karunatx.com. A replay of the webcast will also be archived for up to 30 days on Karuna's website following the completion of the event.
More on Boston Chron
- Sidow Sobrino Announces 12th Album, "Seminal"
- Boston Public Health Commission Encourages People to Get the Flu Shot Ahead of Flu Season
- Asha Therapeutics Selected as a BLUE KNIGHT™ Company by Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA)
- Heartland Soccer Association and VidSport Launch Groundbreaking Live Streaming Service at Garmin Olathe Soccer Complex
- Massachusetts Wins Proposal to Host Northeast Microelectronics Hub through Federal CHIPS and Science Act
About Karuna
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples' lives. For more information, please visit www.karunatx.com.
Contacts
Investors:
Alexis Smith
+1 (518) 338-8990
asmith@karunatx.com
Media:
Bob Josefsberg
+1 (646) 734-3584
bjosefsberg@karunatx.com
Filed Under: Business
0 Comments
Latest on Boston Chron
- HERITAGE FINANCIAL A BARRON'S TOP 100 INDEPENDENT ADVISOR
- Trinity Prairie Real Estate Lists Mesmerizing 16.78-Acre Estate in Colleyville, Texas
- Boston: THE MARY ELIZA PROJECT: WARD 16 VOTER RECORDS NOW AVAILABLE
- Mayor Wu announces a new pilot program to decarbonize Boston's housing stock
- Boston: SCHOOLS URGED TO REGISTER FOR THE BCYF SPELLING BEE
- ACEC/MA Announces Gold Engineering Excellence Award Winners for 2023
- Rhody Rug Revolutionizes Online Shopping Experience with the Launch of their New Direct-to-Consumer Website
- Keches Law Group Attorneys Recognized by Best Lawyers® in 2024 in America
- Long Island businessman turned recording artist, John Beyer, to release his first love song aptly titled, …"Love You More"
- The 2023 CGI Integrated Care Conference Explores Opportunities in Healthcare Improvement Discovered as a Result of the COVID-19 Pandemic
- CVS Health appoints Michael F. Mahoney to its Board of Directors
- Exploring the World of Web3? Lympid Puts Users Front and Center
- JetBlue Adds Amsterdam Service from Boston Starting Today
- Boston: Mayor Wu, Secretary Ed Augustus, and MassHousing Celebrate the Grand Opening of B'Nai B'rith Housing's Parkway 1208 in West Roxbury
- "Regenerating Life": documentary film challenges current assumptions about climate change
- Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- Massachusetts Receives More than $22 Million from USDA to Expand Access to Trees and Green Space
- Flint's Got Talent Returns To Showcase Creativity In Community
- Boston: Chemist Applications Available On Fire Prevention Portal Starting October 1, 2023
- Autonomous eVTOLs $25 Billion Market by 2030